GlassScriptPhysician profile
Megan E Angermayer
NPI 1548899180
$1,452.10
in general payments reported to CMS, 2019-2025
11 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $174 · 2024: $653 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $503.36 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $226.97 | 2024-2025 | Prevena Restor Bellaform, V.A.C. Veraflo, Prevena |
| Axogen | $158.17 | 2025 | |
| Kerecis Limited | $115.69 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $108.08 | 2025 | Restrata Wound Matrix |
| Mentor Worldwide LLC | $100.81 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Extremity Medical | $84.71 | 2024 | |
| Ensemble Orthopedics, INC | $75.34 | 2024 | Ensemble Cmc |
| Avita Medical Americas, LLC | $37.15 | 2023 | Recell |
| Kci USA, INC. | $21.65 | 2023 | Prevena Restor Bellaform, Prevena, V.A.C. Dermatac |
| Janssen Biotech, INC. | $20.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Angermayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.